3:09 PM Abstract No. 132 Complete stasis embolization may convey survival benefit in hepatocellular carcinoma patients treated with doxorubicin eluting bead transcatheter arterial chemoembolization

D. Moon; Scott T. Fujimoto; U. Oyoyo

doi:10.1016/J.JVIR.2018.01.150

3:09 PM Abstract No. 132 Complete stasis embolization may convey survival benefit in hepatocellular carcinoma patients treated with doxorubicin eluting bead transcatheter arterial chemoembolization

D. Moon, Scott T. Fujimoto, U. Oyoyo

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	American English
Pages (from-to)	S59-S60
Journal	Journal of Vascular and Interventional Radiology
Volume	29
Issue number	4
DOIs	https://doi.org/10.1016/J.JVIR.2018.01.150
State	Published - Apr 1 2018

Disciplines

Radiology
Medicine and Health Sciences

Access to Document

10.1016/J.JVIR.2018.01.150License: Unspecified

OpenUrl availability

Full text

Cite this

3:09 PM Abstract No. 132 Complete stasis embolization may convey survival benefit in hepatocellular carcinoma patients treated with doxorubicin eluting bead transcatheter arterial chemoembolization. / Moon, D.; Fujimoto, Scott T.; Oyoyo, U.
In: Journal of Vascular and Interventional Radiology, Vol. 29, No. 4, 01.04.2018, p. S59-S60.

Research output: Contribution to journal › Meeting abstract › peer-review

@article{9d974bac465d4b89aaf15d09f2cbb1a5,

title = "3:09 PM Abstract No. 132 Complete stasis embolization may convey survival benefit in hepatocellular carcinoma patients treated with doxorubicin eluting bead transcatheter arterial chemoembolization",

author = "D. Moon and Fujimoto, {Scott T.} and U. Oyoyo",

note = "Recently Brown et al suggested complete stasis transcatheter arterial embolization (TAE) and complete stasis transcatheter arterial chemoembolization (TACE) have similar outcomes in patients with hepatocellular carcinoma (HCC). In 2011, Jin et al demonstrated higher survival rate with substasis endpoints compared to higher stasis endpoints using conventional TACE (cTACE).",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/J.JVIR.2018.01.150",

language = "American English",

volume = "29",

pages = "S59--S60",

journal = "Journal of Vascular and Interventional Radiology",

number = "4",

}

TY - JOUR

T1 - 3:09 PM Abstract No. 132 Complete stasis embolization may convey survival benefit in hepatocellular carcinoma patients treated with doxorubicin eluting bead transcatheter arterial chemoembolization

AU - Moon, D.

AU - Fujimoto, Scott T.

AU - Oyoyo, U.

N1 - Recently Brown et al suggested complete stasis transcatheter arterial embolization (TAE) and complete stasis transcatheter arterial chemoembolization (TACE) have similar outcomes in patients with hepatocellular carcinoma (HCC). In 2011, Jin et al demonstrated higher survival rate with substasis endpoints compared to higher stasis endpoints using conventional TACE (cTACE).

PY - 2018/4/1

Y1 - 2018/4/1

UR - http://www.jvir.org/article/S1051-0443(18)30150-7/fulltext

U2 - 10.1016/J.JVIR.2018.01.150

DO - 10.1016/J.JVIR.2018.01.150

M3 - Meeting abstract

VL - 29

SP - S59-S60

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 4

ER -

3:09 PM Abstract No. 132 Complete stasis embolization may convey survival benefit in hepatocellular carcinoma patients treated with doxorubicin eluting bead transcatheter arterial chemoembolization

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this